科拓生物 (300858)
Beijing Scitop Bio-tech Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 26349.51
- Circulating A-Shares(W): 19376.46
- Earnings Per Share(RMB): 0.2900
- Net Assets Per Share(RMB): 6.9310
- Operating Revenue(W RMB): 26738.92
- Total Profit(W RMB): 8849.56
- Net Profit Attributable to Parent(W RMB): 7623.20
- Net Profit Growth Rate(%): 7.08
- Weighted Return on Equity(%): 4.2000
- Operating Cash Flow Per Share(RMB): 0.2760
- Undistributed Profit Per Share(RMB): 1.5106
- Capital Reserve Per Share(RMB): 4.2014
2. Main Business
The main business covers:
- Research, production and sales of edible probiotic products
- Research, production and sales of animal and plant microecological preparations
- Research, production and sales of compound food additives
3. Company Basic Information
- Company Name: Beijing Scitop Bio-tech Co., Ltd.
- Listing Date: 2020-07-27
- Industry: Food Manufacturing
- Address: No. 1-2, No. 31 Mangniuhe Road, Yanqi Economic Development Zone, Huairou District, Beijing
- Website: www.scitop.cn
- Company Profile：On November 30, 2016, the shareholders' meeting of Scitop Limited reviewed and approved the overall change of Scitop Limited into a joint stock company based on September 30, 2016. On December 16, 2016, Scitop Bio-tech held its founding meeting, agreeing that all existing shareholders of the company would act as promoters, converting the audited net assets of the limited company into shares, and establishing a joint stock company through overall change. After converting the audited net assets into shares, the registered capital of the joint stock company was 60 million yuan, and the remaining net assets were included in the capital reserve of the joint stock company. On December 28, 2016, the Huairou Branch of the Beijing Administration for Industry and Commerce approved the registration and issued the "Business License" with the unified social credit code 91110116754160123E, with a registered capital of 60 million yuan, and Scitop Limited was wholly changed into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Ningbo Shunyi Venture Capital Partnership (Limited Partnership) | General Legal Person | 2392.60 | 12.35 |
| 2 | Ningbo Kehuida Venture Capital Partnership (Limited Partnership) | General Legal Person | 862.09 | 4.45 |
| 3 | Fullgoal Growth Leading Hybrid Securities Investment Fund | Fund | 660.83 | 3.41 |
| 4 | Basic Pension Fund 16032 Portfolio | Social Security Fund | 525.14 | 2.71 |
| 5 | Fullgoal Balanced Preferred Hybrid Securities Investment Fund | Fund | 424.66 | 2.19 |
| 6 | ICBC Credit Suisse New Generation Consumption Flexible Allocation Hybrid Securities Investment Fund | Fund | 31.00 | 0.16 |
| 7 | Western Lead Quantitative Preferred One-Year Holding Hybrid Securities Investment Fund Class A | Fund | 9.65 | 0.05 |
5. Concept Sectors
- Infant and Child Concept
- Medical Aesthetics Concept
- Helicobacter Pylori
- Innovative Drugs
- Pet Economy
- Imminent Lifting of Trading Restrictions
- Shareholder Reduction
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information